Evaluation of Allogeneic Transplantation in First or Later Minimal Residual Disease-Negative Remission Following Adult-Inspired Therapy for Acute Lymphoblastic Leukemia

Comparisons without hematopoietic cell transplantation (HCT) to myeloablative (MAC) or reduced-intensity HCT (RIC) for adults with acute lymphoblastic leukemia (ALL) in first minimal-residual-disease negative remission (MRD(Neg) CR1) are limited. Further, the importance of MRD(Neg) following salvage...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Leuk Lymphoma
Autors principals: Cassaday, Ryan D., Alan Potts, D., Stevenson, Philip A., Bar, Merav, Georges, George E., Shustov, Andrei R., Sorror, Mohamed L., Wood, Brent L., Delaney, Colleen, Doney, Kristine C., Storb, Rainer F., Sandmaier, Brenda M.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5010422/
https://ncbi.nlm.nih.gov/pubmed/27002921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2016.1160080
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars